BERYL DRUGS LTD. Share Price

₹ 24.99

+₹1.39 (5.89%)
1D
Last updated 03 Nov, 2026, 15:50 IST
BSE: 524606
|
Pharmaceuticals

BERYL DRUGS LTD. Share Price Today

As of 3 Nov 2026, BERYL DRUGS LTD. share price is ₹24.99. The stock opened at ₹22.25, compared to its previous close of ₹23.60. During today's trading session, BERYL DRUGS LTD. share price moved in the range of ₹22.25 to ₹27.00, with an average price of ₹24.63 for the day. Looking at its last 52-week, the stock has touched a low of ₹15.92 and a high of ₹27.90.

Share price over the last 1 day fell from 27.00 to 24.99, ranging between 22.69 and 27.00.
₹22.25
5.89% up today
₹27.00
1D LOW
1D HIGH

BERYL DRUGS LTD. Stock Insights

Stock Performance
OutperformingBeat Nifty by 11.41 % in last 3 month
Shareholding Pattern
PromoterPromoter increased stake by 0.55%
BERYL DRUGS LTD. stock performance
Open₹22.25
High₹27.00
Low₹22.25
Prev. close₹23.60
BERYL DRUGS LTD. trading activity
Volume638
Average traded price₹23.79
Last traded time03:50:00 03 Nov
Last traded quantity45
Circuit
L
H
₹18.88
₹28.32
52-week
L
H
₹15.92
₹27.90
Mkt Cap Cr
11.97
P/E
19.19
P/B
1.21
ROA
4.14%
ROE
4.3%
ROCE
7.56%
Quick Ratio
0.83
EV/EBITDA
6.01

Based on fundamentals, this stock's

Performance: 4 out of 5, Good
Performance
Good
Beryl Drugs outperforming most market indices
Valuation: 1 out of 5, Overvalued
Valuation
Overvalued
Beryl Drugs appears overvalued compared to its peers
Peer Comparison
Peer comparison — key ratios
NameMkt Cap CrP/EP/BROAROEROCEQuick RatioEV/EBITDA
Sun Pharmaceutical Industries4,24,202.4238.614.759.61%13.79%18.65%2.3122.27
Divis Laboratories2,57,902.7390.3115.7614.6%15.32%19.56%3.558.97
Torrent Pharmaceuticals1,74,402.4783.099.494.7%11.42%11.37%0.7533.6
Laurus Labs1,26,811.2895.1720.9211.58%22.11%20.91%0.6854.77
Zydus Lifesciences1,24,089.4826.934.568.57%18.59%17.35%0.9116.42
Dr. Reddy's Laboratories1,11,868.0340.542.884.79%7.21%8.58%1.3519.05
Cipla1,11,647.7239.123.156.6%8.18%10.8%2.521.03
Mankind Pharma1,02,195.6245.155.817.82%12.76%14.68%0.7425.01
Aurobindo Pharma96,951.1826.132.566.34%9.25%11.76%1.1512.38
Lupin91,870.1616.454.0714.47%23.76%24.88%1.429.83

Auto-generated based on historical fundamentals; not a recommendation to buy/sell.

BERYL DRUGS LTD. Company Background

ISIN
INE415H01017
Sector Market Cap
₹ 11.97 Cr

Beryl Drugs Limited is an India-based pharmaceutical manufacturing company which is principally engaged in the manufacturing of bulk drugs. The Company operates in Pharmaceutical Industry segment. In response to product requirements, it provides a variety of manufacturing options, such as small volume injectable in liquid or dry powder form, as well as a selection of eye and ear drops, intravenous (IV) fluids in glass bottles and poly packs, and veterinary medications. It is also involved in domestic, institutional and export supply. The Company uses its nationwide sales and distribution network to market a variety of branded and generic pharmaceutical formulations. Its manufacturing facility is in Pithampur, India.

BERYL DRUGS LTD. Financial Highlights

  • Revenue: BERYL DRUGS LTD. reported revenue of ₹19.31 crore in FY26 vs ₹22.55 crore in FY25. It showed a decrease of 14.37% on a yearly basis.
  • Operating Profit: BERYL DRUGS LTD. reported an operating profit of ₹0.59 crore in FY26 vs ₹0.87 crore in FY25. It showed a decrease of 32.18% on a year-on-year basis.
  • Net Profit: BERYL DRUGS LTD. reported a net profit of ₹0.42 crore in FY26 vs ₹0.58 crore in FY25. It showed a decrease of 27.59% on a yearly basis.

BERYL DRUGS LTD. Quarterly Result Highlights

  • BERYL DRUGS LTD. reported revenue of ₹7.57 crore in Jun 2026, compared with ₹5.47 crore in Mar 2026, representing an increase of 38.39% on a quarter-on-quarter (QoQ) basis.
  • BERYL DRUGS LTD. reported an operating profit of ₹0.27 crore in Jun 2026, compared with ₹0.87 crore in Mar 2026, representing a decrease of 68.97% on a quarter-on-quarter (QoQ) basis.
  • BERYL DRUGS LTD. reported a profit of ₹0.22 crore in Jun 2026, compared with ₹0.56 crore in Mar 2026, reflecting a decrease of 60.71% on a QoQ basis.
  • The earnings per share (EPS) of BERYL DRUGS LTD. stood at ₹0.84 during Jun 2026.

Data Source: BSE, Company announcements

Securities shown are illustrative, not recommendations. Past performance does not guarantee future results.

Promoters
27.97%
FII
0.00%
Other DII
0.00%
Retail and other
72.03%
Mutual funds
0.00%
Foreign Institutional Investor (FII)
FII shareholding by period
Dec 20250.00%
Mar 20260.00%
Jun 20260.00%
Sep 20260.00%

BERYL DRUGS LTD. Investment Returns

1 day
-7.81%
1 week
-5.11%
1 month
-6.68%
1 year
-1.79%
3 years
+10.69%
5 years
+95.69%

BERYL DRUGS LTD. Share Price History

BERYL DRUGS LTD. share price history by day, showing open and close prices and the percentage change
Day
Open / Close
Change %
02 Nov 26
₹23.16 / ₹23.60
-7.81%
30 Oct 26
₹27.00 / ₹25.60
+2.40%
29 Oct 26
₹25.72 / ₹25.00
-3.29%
28 Oct 26
₹27.80 / ₹25.85
+8.84%
Show more

BERYL DRUGS LTD. Financials

Full statement

Income Statement · Standalone

Income Statement · Standalone — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Revenue₹18.82₹21.15₹26.73₹26.89
Other Income₹0.49₹1.41₹0.40₹0.27
Total Revenue₹19.31₹22.55₹27.12₹27.16
Total Expenses₹18.72₹21.69₹26.12₹26.17
Profit Before Tax₹0.59₹0.87₹1.01₹0.98
Tax₹0.16₹0.29₹0.24₹0.22
Profit After Tax₹0.42₹0.58₹0.77₹0.77
EPS - Basic₹0.84₹1.14₹1.52₹1.51
EPS - Diluted₹0.84₹1.14₹1.52₹1.51

Cash Flow · Standalone

Cash Flow · Standalone — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Profit before tax₹0.59₹0.85₹1.01₹0.98
Income before WC changes₹2.29₹2.51₹2.54₹2.09
Change in Assets₹1.28₹2.06-₹0.29₹0.14
Change in Liabilities₹0.24-₹1.09-₹1.23₹0.32
Change in WC₹1.52₹0.96-₹1.52₹0.46
Cash flow from Operations₹3.65₹3.29₹0.82₹2.48
Cash flow from Investing-₹2.16-₹1.05-₹1.08-₹1.30
Cash flow from Financing-₹2.03-₹1.56₹0.10-₹1.17
Total Cash Flow-₹0.54₹0.69-₹0.16₹0.01
Cash (Start of the year)₹0.81₹0.12₹0.28₹0.27
Cash (End of the year)₹0.27₹0.81₹0.12₹0.28

Balance Sheet · Standalone

Balance Sheet · Standalone — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Non-Current Assets₹8.13₹6.92₹7.36₹7.20
Current Assets₹6.83₹9.04₹10.12₹10.32
Total Assets₹14.96₹15.96₹17.49₹17.51
Current Liabilities₹4.48₹4.30₹5.76₹6.33
Net Current Asset₹2.35₹4.74₹4.37₹3.99
Non-Current Liabilities₹0.60₹2.16₹2.81₹3.12
Equity Capital₹9.89₹9.50₹8.92₹8.07
Total Equity & Liabilities₹14.96₹15.96₹17.49₹17.51
* All values are in INR Crore
BERYL DRUGS LTD. market depth
Bid quantityBid priceAsk priceAsk quantity
0024.89100
0024.9953
0000
0000
0000
Total bid quantity0
Total ask quantity153
BERYL DRUGS LTD. technical summary
Bearish indicators2
Neutral indicators5
Bullish indicators1
OverallSlightly Bearish
by SEBI experts

Expert Pick

EXPPICK
Stop-loss
Stop-loss is locked. Sign in to view.
Entry price
Entry price is locked. Sign in to view.
Target
Target is locked. Sign in to view.
Indicator
Value
Verdict
RSI (14)
45.78
Neutral
ATR (14)
2.78
Neutral
STOCH(9,6)
27.12
Neutral
STOCH RSI (14)
2.25
Bullish
ADX(9)
21.38
Bearish
UO(9)
54.6
Neutral
ROC(12)
-5.68
Bearish
WillR(14)
-72.88
Neutral
Period
Simple value
Exponential vaue
5D
24.76
24.64
10D
24.81
24.71
20D
24.81
24.66
50D
24.21
24.19
100D
23.36
23.53
Volume trend — traded volume by day
3 Nov0L
2 Nov0L
30 Oct0L
29 Oct0L
28 Oct0L
27 Oct0L
Average0L

Technical indicators used here are for indicative purposes only. Kindly do not treat it as an investment or trading advice

Compare against other stocks

BERYL DRUGS LTD.
Pharmaceuticals
Add Stock
Add Another

BERYL DRUGS LTD. Returns Calculator

Top Gainers

KRBL Share Price
₹401.45
+38.45 (+10.59%)
MARICO Share Price
₹878.40
+79.85 (+10%)
BALRAMCHIN Share Price
₹654.80
+54.9 (+9.15%)
TRIDENT Share Price
₹23.79
+1.58 (+7.11%)
AEGISLOG Share Price
₹1177.10
+77 (+7%)
See more

Top Losers

KEC Share Price
₹316.35
-32.65 (-9.36%)
GNFC Share Price
₹465.05
-45.95 (-8.99%)
PRAJIND Share Price
₹254.63
-16.5 (-6.09%)
AIAENG Share Price
₹3389.70
-217.6 (-6.03%)
GESHIP Share Price
₹1536.50
-63.9 (-3.99%)
See more

BERYL DRUGS LTD. Share Price FAQs

Please be aware that BERYL DRUGS LTD. stock prices are subject to continuous fluctuations due to various factors.